These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5686839)

  • 1. [Study of anamalous antigens and corresponding antibodies under the influence of 3-oxyanthranilic acid in vivo].
    Korosteleva TA; Zasypka AT
    Vopr Onkol; 1968; 14(9):53-8. PubMed ID: 5686839
    [No Abstract]   [Full Text] [Related]  

  • 2. [Structure and excretion of the formed in vivo antigenic complexes containing 3-oxyanthranilic acid].
    Korosteleva TA; Shvaĭdetskii II
    Vopr Onkol; 1974; 20(12):72-6. PubMed ID: 4475516
    [No Abstract]   [Full Text] [Related]  

  • 3. [Detection of 3-OAA containing antigens at early stages of carcinogenesis].
    Korosteleva TA; Shvaĭdetskiĭ II
    Vopr Onkol; 1977 Jan; 23(1):41-5. PubMed ID: 855237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Content of 3-hydroxyanthranilic acid antigens and antibodies in mice in early stages of hepatocarcinogenesis].
    Korosteleva TA; Shvaĭdetskii II
    Vopr Onkol; 1977; 23(6):73-8. PubMed ID: 411254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antigens and antibodies, circulating in the blood at early stages of experimental hepatocarcinogenesis].
    Korosteleva TA; Potapenkova LS
    Vopr Onkol; 1973; 19(7):53-8. PubMed ID: 4204161
    [No Abstract]   [Full Text] [Related]  

  • 6. [Carcinogenic metabolites of tryptophan].
    Zasypka AT
    Vopr Onkol; 1969; 15(7):108-18. PubMed ID: 4898352
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the formation of anamalous antigens in the early stages of cancerogenesis in the rat liver].
    Korosteleva TA; Khundanova LL
    Vopr Onkol; 1967; 13(5):85-7. PubMed ID: 4971009
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum 3-hydroxyanthranilic acid determination in the early stages of experimental carcinogenesis].
    Korosteleva TA; Zasypka AT
    Vopr Onkol; 1970; 16(10):47-50. PubMed ID: 4995976
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blastomogenic activity of 3-hydroxyanthranilic acid in dogs].
    Khrustalev SA; Khar'kovskaia NA
    Vopr Onkol; 1980; 26(3):93-6. PubMed ID: 7368666
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of beta-naphthylamine as a hapten in early stages of carcinogenesis in dogs].
    Korosteleva TA; Skachkov AP
    Vopr Onkol; 1972; 18(7):69-73. PubMed ID: 5076973
    [No Abstract]   [Full Text] [Related]  

  • 11. A cancer immunosurveillance controversy.
    Qin Z; Blankenstein T
    Nat Immunol; 2004 Jan; 5(1):3-4; author reply 4-5. PubMed ID: 14699396
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dynamics of carcinogen-protein antigenic complexes in the carcinogenesis process].
    Korosteleva TA; Shvaĭdetskiĭ II
    Vopr Onkol; 1982; 28(3):88-91. PubMed ID: 6801856
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cellular sensitization to fetal antigens during chemical carcinogenesis].
    Pasternak G; Schlott B; Gryschek G; von Broen B; Albrecht S; Reinhöfer J
    Biomed Biochim Acta; 1983; 42(6):777-84. PubMed ID: 6639648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dual effect of antibodies against sex-linked histocompatibility antigen.
    Bubeník J; Adamcová B; Koldovský P
    Folia Biol (Praha); 1966; 12(1):11-7. PubMed ID: 5913580
    [No Abstract]   [Full Text] [Related]  

  • 15. Different H-2 antigens expressed on two tumors derived from one BALB/c mouse.
    Garrido F; Perez M; Iványi P; Schirrmacher V
    Transplant Proc; 1981 Dec; 13(4):1824-7. PubMed ID: 7330970
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of ethyl alcohol on the carcinogenic activity of N-nitrosodi-n-propylamine.
    Griciute L; Castegnaro M; Bereziat JC
    IARC Sci Publ; 1982; (41):643-8. PubMed ID: 7141571
    [No Abstract]   [Full Text] [Related]  

  • 17. [In vivo methylation of rat liver RNA and under the influence of diethylnitrosamine].
    Kröger H; Kahle P; Kessel H
    Hoppe Seylers Z Physiol Chem; 1968 Dec; 349(12):1725-32. PubMed ID: 5707039
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor promotion by 1-fluoro-2,4-dinitrobenzene, a potent skin sensitizer.
    Bock FG; Fjelde A; Fox HW; Klein E
    Cancer Res; 1969 Jan; 29(1):179-82. PubMed ID: 5763975
    [No Abstract]   [Full Text] [Related]  

  • 19. Incorporating the concept of 'invaders' and 'defenders' in the dose-response modeling of carcinogens.
    Stevenson DE; Sielken RL
    Prog Clin Biol Res; 1995; 391():445-51. PubMed ID: 8532736
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural antitumor resistance in immune-deficient mice.
    Stutman O
    Exp Cell Biol; 1984; 52(1-2):30-9. PubMed ID: 6321257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.